Microenvironment Expression in Diffuse Large B-Cell Lymphomas

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Lenalidomide in Diffuse Large B-Cell Lymphomas

Advances in Hematology
Hematology
2012English

Diffuse Large B-Cell Lymphomas Are Metabolically Heterogeneous

Cancer Discovery
Oncology
2012English

Prognostic Significance of in Situ Phenotypic Marker Expression in Diffuse Large B-Cell Lymphomas

Biomarker Insights
BiochemistryMolecular MedicinePharmacology
2007English

Clinical Implications of SPRR1A Expression in Diffuse Large B-Cell Lymphomas: A Prospective, Observational Study

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

De Novo CD5-positive Diffuse Large B-Cell Lymphomas Show High Specificity for Cyclin D2 Expression

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2013English

Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

Oncologist
Cancer ResearchMedicineOncology
2018English

A Study of the Newer Prognostic Markers in Diffuse Large B Cell Lymphomas

Medical Journal Armed Forces India
Medicine
2011English

Novel BCL6 Inhibitor (FX1): Advances in Diffuse Large B-Cell Lymphomas (DLBCLs) Treatment

Biomedical Sciences
2017English

FBXO11 Targets BCL6 for Degradation and Is Inactivated in Diffuse Large B-Cell Lymphomas

Nature
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy